Johnson & Johnson has suspended sales of its laparoscopic power morcellators worldwide, according to a Medscape report.
The company stopped selling the device following a warning by the U.S. Food and Drug Administration saying morcellators present a serious risk of spreading cancerous tissue.
In March, Massachusetts General Hospital and Brigham and Women's Hospital in Boston changed their protocols on morcellation procedures after two cases resulted in the spreading of cancerous tissue into the abdomen.
More Articles on Hospital Supply Chain:
FDA Proposes Reclassifying Surgical Mesh as 'High-Risk Device'
Drug Supply Chain & Security Act Implementation Timeline
6 Strategies to Conserve IV Solution